CORRESP 1 filename1.htm nby20191031_corresp.htm

 

 

November 1, 2019

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:

NovaBay Pharmaceuticals, Inc. (the “Company”)

Form S-1, File No. 333-234330

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective as of 5:00 p.m. (Eastern time) on Tuesday, November 5, 2019, or as soon as practicable thereafter.

 

 

   

Very truly yours,
       
   

NovaBay Pharmaceuticals, Inc.
       
       
   

By:

 /s/ Justin Hall 
     

Justin Hall
     

President & Chief Executive Officer and General Counsel
       
       

cc:

Abby E. Brown, Squire Patton Boggs (US) LLP